Stifel raised the firm’s price target on OrthoPediatrics (KIDS) to $22 from $20 and keeps a Buy rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KIDS:
- OrthoPediatrics price target raised to $24 from $23 at BTIG
- OrthoPediatrics Highlights Growth Strategy in 2026 Investor Presentation
- OrthoPediatrics announces iotaMotion received FDA 510k clearance for iotaSOFT
- OrthoPediatrics initiated with a Buy at TD Cowen
- OrthoPediatrics (KIDS): Pediatric Ortho Leader in an Underpenetrated Market with Improving Profitability and Valuation Upside